Thursday, 5 December 2024 | 13:50 - 14:10
LiveTreg Trial - A Phase I/IIa open label single ascending dose study to assess safety and tolerability of regulatory T cells to promote discontinuation of tacrolimus monotherapy in liver transplant recipients
Format:In-person
- In vivo engraftment (part 1)